Status:
COMPLETED
Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava
Lead Sponsor:
University Hospital Ostrava
Conditions:
Nasal Polyps
Nasal Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagno...
Detailed Description
INTRODUCTION Squamous cell carcinoma antigen (SCCA) is a protein with a strong homology to the family of protease inhibitors known as serpins. SCCAs are cytoplasmic proteins: they are found in normal ...
Eligibility Criteria
Inclusion
- at least three-year follow-up following the surgical procedure
- signed Informed Consent
Exclusion
- patient lost during follow-up
- patients in critical condition (ASA IV)
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01827423
Start Date
January 1 2000
End Date
January 1 2012
Last Update
April 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia, 70800